Dijon, France · Founded 2016 · Privately Held (backing)
Developer of immunotherapies designed to help harness the therapeutic potential of gut microbiota. Exeliom Biosciences is based in Dijon, France and was founded in 2016. Its last reported valuation was $7.4 million in Dec 2018. It has raised $33.3 million.
Last reported valuation
$7.4M
Oct 2026
Priced at
—
Total raised
$33.3M
Last round
—
Team — not yet on record
No current team members for Exeliom Biosciences are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Exeliom Biosciences with a free account
·The complete investor list: 19 names
·Watch Exeliom Biosciences: the Monday email on marks, rounds and moves
